K E Y W W W.C M O L E A D E R S H I PA W A R D S .C O M
2016
CMO
LEADERSHIP
AWARDS
WINNERS
Company
Profiles
LIFESCIENCELEADER.COM THE CMO LEADERSHIP AWARDS 2016
62
CAPABILITIES COMPATIBILITY EXPERTISE QUALITY RELIABILITY
INDIVIDUAL ATTRIBUTE AWARDS: accessible
senior management, innovation, reputation, right
first time, state-of-the-art, strength of science
INDIVIDUAL ATTRIBUTE AWARDS: accessible
senior management, cultural fit, reputation, right
first time
SERVICES & CAPABILITIES: aseptic fill/finish,
cartridges, controlled substances, generics,
injectables, liquids, lyophilized products,
ophthalmics, parenterals (large volume),
parenterals (small volume), peptides, proteins,
solutions & suspensions, sterile, sustained
release, syringes (pre-filled), vaccines
"Vetter is thrilled to win this award, particularly
in four categories of critical importance to our
customers. Quality, expertise, capabilities, and
compatibility are among the major success
factors for our business, and well represent our
continuous efforts to perform at a high level,
meeting or exceeding customers' expectations.
That is the philosophy of Vetter and the goal of our
employees. This award is a reflection of the pride
we take in achieving superior results."
SERVICES & CAPABILITIES: capsules,
controlled substances, cytotoxic & high potency
compounds, liquids, nonsterile, powders
(nonsterile), solid dose, solutions & suspensions,
sustained release
"We are extremely honored to receive this
recognition of excellence from our clients and
peers. While we strive to be the best in all that
we do, it is the award for quality that resonates
the loudest throughout our organization. Quality
is the virtue that stands behind every email, every
process, and every delivery Xcelience makes.
Every other skill we excel at may be traced to our
overriding pursuit of quality."
DRUG TYPE:
Pharmaceuticals, Biopharmaceuticals
DRUG TYPE:
Pharmaceuticals
DRUG LIFE CYCLE STAGES:
Research & Development: Preclinical, Clinical
(Phase 1, Phase 2, Phase 3)
Drug Substance Production: Primary Process
Development, Drug Substance Production
Formulated Drug Production: Dosage Form
Development, Dosage Form Production,
Packaging, Logistics
DRUG LIFE CYCLE STAGES:
Research & Development: Preclinical, Clinical
(Phase 1, Phase 2, Phase 3)
Formulated Drug Production: Dosage Form
Development, Dosage Form Production,
Packaging, Logistics
PETER SOELKNER
Managing Director
DEREK HENNECKE
President & CEO
CATEGORIES WON CATEGORIES WON
Xcelience
Tampa, FL
www.xcelience.com
+1 813 286 0404
Sharon Burgess
sharon.burgess@xcelience.como
Key locations: Tampa, FL, Quakertown, PA
Vetter Pharma International GmbH
Ravensburg, Germany
www.vetter-pharma.com
+49 751 3700 0
Oskar Gold
info@vetter-pharma.com
Key locations: Vetter Schuetzenstrasse GMP,
Germany; Ravensburg Vetter South GMP, Germany;
Vetter Langenargen GMP, Germany; Ravensburg
Vetter West, Germany